top of page
News


Theolytics is taking part in the BIA Research Relay 2021
We’re delighted to announce that we’re all taking part in the BioIndustry Association’s Research Relay 2021 to raise money for Ovarian Cancer Action . As a team, we’re committing to walking 2000km throughout the month of May so Ovarian Cancer Action can continue their brilliant work in the fight against a cancer that affects 295,000 women every year. The disease is difficult to detect early and complicated to treat, meaning half of these women will not survive beyond five ye
Jul 1, 2021


Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures
Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies. Oxford, UK, 7th January 2020 Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round. The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI). The financing will be used to progress t
Jan 7, 2020
bottom of page
